Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000939767-25-000036)

Filing Details

Accession Number:: 0000939767-25-000036
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-26 20:00:59
Reporting Period:: 2025-02-25

Filing Date:: 2025-02-26
Accepted Time:: 2025-02-26 20:00:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
939767	Exelixis Inc.	EXEL	Biological Products, (No Disgnostic Substances) (2836)	043257395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1694534	Bob Oliver	C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-25	15,147	$19.28	52,161	No	4	M	Direct
Common Stock	Disposition	2025-02-25	18,647	$37.25	33,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2025-02-25	15,147	$0.00	15,147	$19.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,206	2023-05-31	2030-05-30	No	4	M	Direct

Footnotes

Includes 32,470 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economicequivalent of one share of Common Stock.
The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.